New York, NY (PRWEB) October 13, 2013
Thousands of federally-filed Pradaxa lawsuit (http://www.pradaxalawsuithelp.com/) claims took a step forward this month with a recent status conference that discussed matters vital to the litigation currently underway in the U.S. District Court, Southern District of Illinois, along with an update reflecting numerous additions to its case list, Bernstein Liebhard LLP reports.
According to Minutes published October 8th on the Courts website, the federal proceedings latest Conference covered a range of issues relevant to cases alleging Pradaxa bleeding side effects caused by the blood-thinning drug.* The scheduling of depositions, as well as updates on the litigations upcoming bellwether case selection were among the items listed on the Courts agenda. The next status conference in the federal Pradaxa proceeding, which now includes more than 1,600 cases, was also set for November 6th, 2013 at 9:00 a.m. (In Re: Pradaxa (Dabigatran Etexilate) Products Liability Litigation MDL No. 2385)
Our Firm continues to hear from individuals who allegedly experienced frightening episodes of Pradaxa bleeding, so we are pleased to see this litigation moving forward, says Bernstein Liebhard LLP, a nationwide law firm representing individuals harmed by defective drugs and medical devices. The Firm is currently offering free case reviews to potential Pradaxa lawsuit claimants who may have suffered life-threatening internal bleeding injuries associated with the blood thinner.
A recent Case List update shows a total of 1,622 Pradaxa lawsuit claims now pending in the federal Illinois proceeding. These cases similarly allege that Boehringer Ingelheim failed to warn about Pradaxas potential to cause cerebral hemorrhaging, gastrointestinal bleeding, and other life-threatening internal bleeding injuries in patients taking the medication.
Pradaxa was approved in October 2010 by the U.S. Food and Drug Administration (FDA) to treat patients with atrial fibrillation. Then marketed as an improvement over warfarin, a blood-thinner prescribed for generations, the Boehringer-manufactured medication has since become a growing concern to federal regulators who have issued numerous safety alerts about the possibility for users to experience Pradaxa bleeding side effects, according to Bloomberg.com.*
What makes potential Pradaxa bleeding side effects so dangerous is that there is no readily available antidote to reverse them, while internal bleeding from warfarin can be stopped with the administration of vitamin K. The findings of a study published in January 2013 by the Institute for Safe Medicine Practices revealed that individuals who experienced episodes of Pradaxa bleeding were 5 times more likely to die than those who had suffered bleeding while taking warfarin.
Individuals who may have experienced life-threatening Pradaxa bleeding side effects may be eligible to receive compensation for out-of-pocket medical expenses, lost wages, pain and suffering and more. Click here to speak with a Pradaxa lawyer at Bernstein Liebhard LLP today. You may also receive a free case review from a member of the Firms team of legal professionals by calling 800-511-5092.
**bloomberg.com/news/2012-12-11/boehringer-sued-by-hundreds-over-bleeding-tied-to-pradaxa.html, Bloomberg.com, December 11, 2012
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the top plaintiffs firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016